Dr. Richard H. Carmona, 17th United States Surgeon General, Joins TASER International Board of Directors

    SCOTTSDALE, Ariz., March 13 /PRNewswire-FirstCall/ -- TASER
 International, Inc. (Nasdaq:   TASR), a market leader in advanced electronic
 control devices, today announced that the 17th Surgeon General of the
 United States, Richard H. Carmona, M.D., M.P.H., FACS, has joined the Board
 of Directors of TASER International, Inc. effective March 8, 2007. Dr.
 Carmona served the four-year term as U.S. Surgeon General from 2002 to
 2006. He brings nearly 40 years of military, law enforcement, and medical
 experience to his role as a member of the TASER Board of Directors. Dr.
 Carmona currently serves as vice chairman of Canyon Ranch, CEO of Canyon
 Ranch Health, and president of the nonprofit Canyon Ranch Institute in
 Tucson, Arizona. Dr. Carmona is also the Distinguished Professor of Public
 Health at The University of Arizona Mel and Enid Zuckerman College of
 Public Health.
     With the addition of Dr. Carmona, TASER International has nine members
 of its Board of Directors, including seven outside Directors.
     "Dr. Carmona's extensive experience in the medical, military and law
 enforcement fields will provide added strategic focus to our goal of
 advancing TASER technology today and in the future. With these unique
 disciplines and background, Dr. Carmona is a tremendous addition to our
 board. We are looking forward to sharing his expertise as we develop and
 advance the benefits of TASER(R) technology throughout the world," said
 TASER International Chairman of the Board Tom Smith.
     Biography
     Born and raised in New York City, Dr. Carmona dropped out of high
 school and enlisted in the U.S. Army in 1967. While enlisted, he received
 his Army General Equivalency Diploma, joined the Army's Special Forces,
 ultimately becoming a combat-decorated Vietnam veteran, and began his
 career in medicine.
     After leaving active duty, Dr. Carmona attended Bronx Community College
 of the City University of New York, where he earned his associate of arts
 degree. He later attended and graduated from the University of California,
 San Francisco, with a bachelor of science degree (1977) and medical degree
 (1979). At the University of California Medical School, Dr. Carmona was
 awarded the prestigious gold-headed cane as the top graduate. He has also
 earned a masters of public health from the University of Arizona (1998).
     Dr. Carmona has worked in various positions in the medical field,
 including paramedic, registered nurse, and physician. He is a Fellow of the
 American College of Surgeons, and is also certified in correctional health
 care and in quality assurance.
     In 2002 Dr. Carmona was nominated by President George W. Bush and
 unanimously confirmed by the United States Senate to become the 17th
 Surgeon General of the United States. As Surgeon General, Dr. Carmona
 focused on prevention, preparedness, health disparities, health literacy
 and global health to include health diplomacy. He also issued many landmark
 Surgeon General communications during his tenure, including the definitive
 Surgeon General's Report about the dangers of second-hand smoke (2006).
     Prior to being named Surgeon General, Dr. Carmona was the chairman of
 the State of Arizona Southern Regional Emergency Medical System; and a
 professor of surgery, public health, and family and community medicine at
 the University of Arizona.
     Dr. Carmona has served for over 20 years with the Pima County Sheriff's
 Department in Tucson, including as deputy sheriff, surgeon, and SWAT team
 leader. He is one of the most highly decorated police officers in Arizona,
 and his numerous awards include the National Top Cop Award, the National
 SWAT Officer of the Year, and the National Tactical EMS Award. Dr. Carmona
 is a nationally recognized SWAT expert and has published extensively on
 SWAT training and tactics, forensics, and tactical emergency medical
 support. Dr. Carmona has also served as a medical director of police and
 fire departments and is a fully qualified peace officer with expertise in
 special operations and emergency preparedness, including weapons of mass
 destruction.
     After completing his four-year term as Surgeon General in 2006, Dr.
 Carmona was named to the position of vice chairman for Canyon Ranch, the
 country's leading health and wellness company for over 25 years. He also
 serves as chief executive officer of the company's Health Division and
 oversees health strategy and policy for all Canyon Ranch businesses. He is
 president of the nonprofit Canyon Ranch Institute and the recipient of the
 first Distinguished Professorship in Public Health at the University of
 Arizona's Mel and Enid Zuckerman College of Public Health. Dr. Carmona has
 received numerous awards, decorations, and local and national recognition
 for his achievements. A strong supporter of community service, he serves on
 community and national boards and provides leadership to many diverse
 organizations.
     About TASER International, Inc.
     TASER International provides advanced electronic control devices for
 use in the law enforcement, military, private security and personal defense
 markets. TASER devices use proprietary technology to incapacitate
 dangerous, combative or high-risk subjects who pose a risk to law
 enforcement officers, innocent citizens or themselves in a manner that is
 generally recognized as a safer alternative to other uses of force. TASER
 technology saves lives every day, and the use of TASER devices dramatically
 reduces injury rates for police officers and suspects. For more information
 on TASER life-saving technology, please call TASER International at (800)
 978-2737 or visit our website at http://www.TASER.com.
     Note to Investors
     This press release contains forward-looking statements within the
 meaning of Section 27A of the Securities Act of 1933, as amended (the
 "Securities Act"), and Section 21E of the Securities Exchange Act of 1934,
 as amended (the "Exchange Act"), including statements, without limitation,
 regarding our expectations, beliefs, intentions or strategies regarding the
 future. We intend that such forward-looking statements be subject to the
 safe-harbor provided by the Private Securities Litigation Reform Act of
 1995. The forward-looking information is based upon current information and
 expectations regarding TASER International. These estimates and statements
 speak only as of the date on which they are made, are not guarantees of
 future performance, and involve certain risks, uncertainties and
 assumptions that are difficult to predict. Therefore, actual outcomes and
 results could materially differ from what is expressed, implied, or
 forecasted in such forward-looking statements.
     TASER International assumes no obligation to update the information
 contained in this press release. These statements are qualified by
 important factors that could cause our actual results to differ materially
 from those reflected by the forward-looking statements. Such factors
 include but are not limited to: (1) market acceptance of our products; (2)
 our ability to establish and expand direct and indirect distribution
 channels; (3) our ability to attract and retain the endorsement of key
 opinion-leaders in the law enforcement community; (4) the level of product
 technology and price competition for our products; (5) the degree and rate
 of growth of the markets in which we compete and the accompanying demand
 for our products; (6) risks associated with rapid technological change and
 new product introductions; (7) competition; (8) litigation including
 lawsuits resulting from alleged product related injuries and death; (9)
 media publicity concerning allegations of deaths and injuries occurring
 after use of the TASER device and the negative effect this publicity could
 have on our sales; (10) TASER device tests and reports; (11) product
 quality; (12) implementation of manufacturing automation; (13) potential
 fluctuations in our quarterly operating results; (14) financial and
 budgetary constraints of prospects and customers; (15) order delays; (16)
 dependence upon sole and limited source suppliers; (17) negative reports
 concerning the TASER device; (18) fluctuations in component pricing; (19)
 government regulations and inquiries; (20) dependence upon key employees
 and our ability to retain employees; (21) execution and implementation
 risks of new technology; (22) ramping manufacturing production to meet
 demand; (23) medical and safety studies; and (24) other factors detailed in
 our filings with the Securities and Exchange Commission, including, without
 limitation, those factors detailed in the Company's Annual Report on Form
 10-K and its Form 10-Qs.
     The statements made herein are independent statements of TASER
 International. The inclusion of any third parties does not represent an
 endorsement of any TASER International products or services by any such
 third parties.
 
 

SOURCE TASER International, Inc.